|Day's range||0.00 - 0.00|
|PE ratio (TTM)||18.28|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|
Novo Nordisk (NVO) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Novo Nordisk A/S. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
Novo Nordisk, Celgene, and Bayer should get the biggest bang for the buck on their R&D and acquisitions.